259 related articles for article (PubMed ID: 32328198)
1. Untargeted Metabolomics Analysis of Esophageal Squamous Cell Carcinoma Discovers Dysregulated Metabolic Pathways and Potential Diagnostic Biomarkers.
Zhu ZJ; Qi Z; Zhang J; Xue WH; Li LF; Shen ZB; Li ZY; Yuan YL; Wang WB; Zhao J
J Cancer; 2020; 11(13):3944-3954. PubMed ID: 32328198
[No Abstract] [Full Text] [Related]
2. Untargeted metabolomics analysis of esophageal squamous cell cancer progression.
Yang T; Hui R; Nouws J; Sauler M; Zeng T; Wu Q
J Transl Med; 2022 Mar; 20(1):127. PubMed ID: 35287685
[TBL] [Abstract][Full Text] [Related]
3. Serum Metabolomics for Biomarker Screening of Esophageal Squamous Cell Carcinoma and Esophageal Squamous Dysplasia Using Gas Chromatography-Mass Spectrometry.
Zhang S; Lu X; Hu C; Li Y; Yang H; Yan H; Fan J; Xu G; Abnet CC; Qiao Y
ACS Omega; 2020 Oct; 5(41):26402-26412. PubMed ID: 33110968
[TBL] [Abstract][Full Text] [Related]
4. Tissue-based metabolomics reveals metabolic biomarkers and potential therapeutic targets for esophageal squamous cell carcinoma.
Chen Z; Gao Y; Huang X; Yao Y; Chen K; Zeng S; Mao W
J Pharm Biomed Anal; 2021 Apr; 197():113937. PubMed ID: 33609949
[TBL] [Abstract][Full Text] [Related]
5. Global and targeted metabolomics of esophageal squamous cell carcinoma discovers potential diagnostic and therapeutic biomarkers.
Xu J; Chen Y; Zhang R; Song Y; Cao J; Bi N; Wang J; He J; Bai J; Dong L; Wang L; Zhan Q; Abliz Z
Mol Cell Proteomics; 2013 May; 12(5):1306-18. PubMed ID: 23397110
[TBL] [Abstract][Full Text] [Related]
6. A multi-platform metabolomics reveals possible biomarkers for the early-stage esophageal squamous cell carcinoma.
Zhao J; Zhao X; Yu J; Gao S; Zhang M; Yang T; Liu L
Anal Chim Acta; 2022 Aug; 1220():340038. PubMed ID: 35868700
[TBL] [Abstract][Full Text] [Related]
7. Plasma Metabolomics Reveals Diagnostic Biomarkers and Risk Factors for Esophageal Squamous Cell Carcinoma.
Yu M; Wen W; Yi X; Zhu W; Aa J; Wang G
Front Oncol; 2022; 12():829350. PubMed ID: 35198450
[TBL] [Abstract][Full Text] [Related]
8. Purine salvage-associated metabolites as biomarkers for early diagnosis of esophageal squamous cell carcinoma: a diagnostic model-based study.
Sun Y; Liu W; Su M; Zhang T; Li X; Liu W; Cai Y; Zhao D; Yang M; Zhu Z; Wang J; Yu J
Cell Death Discov; 2024 Mar; 10(1):139. PubMed ID: 38485739
[TBL] [Abstract][Full Text] [Related]
9. Global metabolomics reveals potential urinary biomarkers of esophageal squamous cell carcinoma for diagnosis and staging.
Xu J; Chen Y; Zhang R; He J; Song Y; Wang J; Wang H; Wang L; Zhan Q; Abliz Z
Sci Rep; 2016 Oct; 6():35010. PubMed ID: 27725730
[TBL] [Abstract][Full Text] [Related]
10. Towards Tyrosine Metabolism in Esophageal Squamous Cell Carcinoma.
Cheng J; Zheng G; Jin H; Gao X
Comb Chem High Throughput Screen; 2017; 20(2):133-139. PubMed ID: 28000565
[TBL] [Abstract][Full Text] [Related]
11. Activation of choline kinase drives aberrant choline metabolism in esophageal squamous cell carcinomas.
Ma W; Wang S; Zhang T; Zhang EY; Zhou L; Hu C; Yu JJ; Xu G
J Pharm Biomed Anal; 2018 Jun; 155():148-156. PubMed ID: 29631075
[TBL] [Abstract][Full Text] [Related]
12. Serum metabolomics analysis for the progression of esophageal squamous cell carcinoma.
Li X; Zhao L; Wei M; Lv J; Sun Y; Shen X; Zhao D; Xue F; Zhang T; Wang J
J Cancer; 2021; 12(11):3190-3197. PubMed ID: 33976728
[No Abstract] [Full Text] [Related]
13. Serum Metabolomic Profiling Reveals Biomarkers for Early Detection and Prognosis of Esophageal Squamous Cell Carcinoma.
Wang PP; Song X; Zhao XK; Wei MX; Gao SG; Zhou FY; Han XN; Xu RH; Wang R; Fan ZM; Ren JL; Li XM; Wang XZ; Yang MM; Hu JF; Zhong K; Lei LL; Li LY; Chen Y; Chen YJ; Ji JJ; Yang YZ; Li J; Wang LD
Front Oncol; 2022; 12():790933. PubMed ID: 35155234
[TBL] [Abstract][Full Text] [Related]
14. Identification of plasma metabolomic profiling for diagnosis of esophageal squamous-cell carcinoma using an UPLC/TOF/MS platform.
Liu R; Peng Y; Li X; Wang Y; Pan E; Guo W; Pu Y; Yin L
Int J Mol Sci; 2013 Apr; 14(5):8899-911. PubMed ID: 23615477
[TBL] [Abstract][Full Text] [Related]
15. Disturbed tryptophan metabolism correlating to progression and metastasis of esophageal squamous cell carcinoma.
Cheng J; Jin H; Hou X; Lv J; Gao X; Zheng G
Biochem Biophys Res Commun; 2017 May; 486(3):781-787. PubMed ID: 28342863
[TBL] [Abstract][Full Text] [Related]
16. Combined Metabolomic Analysis of Plasma and Tissue Reveals a Prognostic Risk Score System and Metabolic Dysregulation in Esophageal Squamous Cell Carcinoma.
Chen Z; Dai Y; Huang X; Chen K; Gao Y; Li N; Wang D; Chen A; Yang Q; Hong Y; Zeng S; Mao W
Front Oncol; 2020; 10():1545. PubMed ID: 32984013
[No Abstract] [Full Text] [Related]
17. Development of a metabolic pathway-based pseudo-targeted metabolomics method using liquid chromatography coupled with mass spectrometry.
Xu J; Li J; Zhang R; He J; Chen Y; Bi N; Song Y; Wang L; Zhan Q; Abliz Z
Talanta; 2019 Jan; 192():160-168. PubMed ID: 30348373
[TBL] [Abstract][Full Text] [Related]
18. Exploring potential biomarkers of early stage esophageal squamous cell carcinoma in pre- and post-operative serum metabolomic fingerprint spectrum using
Yang Z; Liu Y; Ma L; Wen X; Ji H; Li K
Am J Transl Res; 2019; 11(2):819-831. PubMed ID: 30899382
[TBL] [Abstract][Full Text] [Related]
19. Untargeted serum metabolomics reveals potential biomarkers and metabolic pathways associated with the progression of gastroesophageal cancer.
Che J; Zhao Y; Gu B; Li S; Li Y; Pan K; Sun T; Han X; Lv J; Zhang S; Fan B; Li C; Wang C; Wang J; Zhang T
BMC Cancer; 2023 Dec; 23(1):1238. PubMed ID: 38102546
[TBL] [Abstract][Full Text] [Related]
20. Study on plasma amino acids and piperonamide as potential diagnostic biomarkers of non-small cell lung cancer.
Zhang C; Wang Y; Cao Y; Shi L; Wang R; Sheng N; Wang Q; Zhu Z
Transl Cancer Res; 2022 May; 11(5):1269-1284. PubMed ID: 35706818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
